Dual inhibition of the α-glucosidase and butyrylcholinesterase studied by molecular field topology analysis.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  European journal of medicinal chemistry

• Publication date

  2014-06-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejmech.2014.04.018PMID 24780600
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel computational approaches to polypharmacology as a means to define responses to individual drugs.

  2012cited by this paper
• Quantitative Structure-Activity/Property Relationships: The Ubiquitous Links between Cause and Effect

  2012cited by this paper
• The exploration of thienothiazines as selective butyrylcholinesterase inhibitors.

  2012cited by this paper
• Human butyrylcholinesterase knock-out equivalent: Potential to assess role in Alzheimer's disease

  2012cited by this paper
• Identification and characterization of diarylimidazoles as hybrid inhibitors of butyrylcholinesterase and amyloid beta fibril formation.

  2012cited by this paper
• Hologram QSAR Models of 4-[(Diethylamino)methyl]-phenol Inhibitors of Acetyl/Butyrylcholinesterase Enzymes as Potential Anti-Alzheimer Agents

  2012cited by this paper
• Microscopic binding of butyrylcholinesterase with quinazolinimine derivatives and the structure–activity correlation

  2011cited by this paper
• Structural analysis of α-glucosidase inhibitors by validated QSAR models using topological and hydrophobicity based descriptors

  2011cited by this paper
• Linking type 2 diabetes and Alzheimer's disease

  2010cited by this paper
• Efficacy and safety of vildagliptin and voglibose in Japanese patients with type 2 diabetes: a 12-week, randomized, double-blind, active-controlled study

  2010cited by this paper
• QSAR Studies on Andrographolide Derivatives as α-Glucosidase Inhibitors

  2010cited by this paper
• Quantitative structure activity relationship for the computational prediction of α-glucosidase inhibitory

  2009cited by this paper
• Galinsosides A and B, bioactive flavanone glucosides from Galinsoga parviflora

  2009cited by this paper
• Ligand‐based 3D‐QSAR Studies of Physostigmine Analogues as Acetylcholinesterase Inhibitors

  2009cited by this paper
• The alpha-glucosidase inhibitor miglitol delays the development of diabetes and dysfunctional insulin secretion in pancreatic beta-cells in OLETF rats.

  2009cited by this paper
• Novel easily accessible glucosidase inhibitors: 4-hydroxy-5-alkoxy-1,2-cyclohexanedicarboxylic acids.

  2009cited by this paper
• Design, synthesis and pharmacological evaluation of hybrid molecules out of quinazolinimines and lipoic acid lead to highly potent and selective butyrylcholinesterase inhibitors with antioxidant properties.

  2008cited by this paper
• Receptor-Based Modeling and 3D-QSAR for a Quantitative Production of the Butyrylcholinesterase Inhibitors Based on Genetic Algorithm

  2008cited by this paper
• Predicting antimicrobial drugs and targets with the MARCH-INSIDE approach.

  2008cited by this paper
• Artificial neural networks from MATLAB in medicinal chemistry. Bayesian-regularized genetic neural networks (BRGNN): application to the prediction of the antagonistic activity against human platelet thrombin receptor (PAR-1).

  2008cited by this paper
• Toward the Virtual Screening of α-Glucosidase Inhibitors with the Homology-Modeled Protein Structure

  2008cited by this paper
• Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery.

  2008cited by this paper
• Current topics on software use in medicinal chemistry: intellectual property, taxes, and regulatory issues.

  2008cited by this paper
• Effects of sources of carbon and nitrogen on production of α-glucosidase inhibitor by a newly isolated strain of Bacillus subtilis B2.

  2008cited by this paper
• Variable selection methods in QSAR: an overview.

  2008cited by this paper
• Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors.

  2008cited by this paper
• Quantitative structure-activity relationship studies of HIV-1 integrase inhibition. 1. GETAWAY descriptors.

  2007cited by this paper
• Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine.

  2007cited by this paper
• Butyrylcholinesterase Inhibitory Triterpenes from Salsola baryosma.

  2007cited by this paper
• Medicinal chemistry and bioinformatics--current trends in drugs discovery with networks topological indices.

  2007cited by this paper
• Alpha-glucosidase inhibition of natural curcuminoids and curcumin analogs.

  2006cited by this paper
• Synthesis and pharmacological activities of xanthone derivatives as alpha-glucosidase inhibitors.

  2006cited by this paper
• Lipids in Health and Disease

  2006cited by this paper
• Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent

  2005cited by this paper
• Macroalage as a source of alpha-glucosidase inhibitors

  2005cited by this paper
• Alpha-glucosidase inhibitors for type 2 diabetes mellitus.

  2005cited by this paper
• Syntheses and Biological Activities of Chalcone and 1,5‐Benzothiazepine Derivatives: Promising New Free‐Radical Scavengers, and Esterase, Urease, and α‐Glucosidase Inhibitors

  2005cited by this paper
• Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent.

  2005cited by this paper
• Quantitative structure-activity relationship to predict differential inhibition of aldose reductase by flavonoid compounds.

  2005cited by this paper
• Isolation and Characterization of α-Glucosidase Inhibitor from the Fungus Ganoderma lucidum

  2004cited by this paper
• Isolation and characterization of alpha-glucosidase inhibitor from the fungus Ganoderma lucidum.

  2004cited by this paper
• Selective Inhibitors of Butyrylcholinesterase

  2001cited by this paper
• Selective inhibitors of butyrylcholinesterase: a valid alternative for therapy of Alzheimer's disease?

  2001cited by this paper
• Molecular Field Topology Analysis Method in QSAR Studies of Organic Compounds

  2000cited by this paper
• Molecular descriptors in QSAR/QSPR

  2000cited by this paper
• Potential of α-Glucosidase Inhibitors in Elderly Patients with Diabetes Mellitus and Impaired Glucose Tolerance

  1998cited by this paper
• Potential of alpha-glucosidase inhibitors in elderly patients with diabetes mellitus and impaired glucose tolerance.

  1998cited by this paper
• Distribution of butyrylcholinesterase in the human amygdala and hippocampal formation

  1998cited by this paper
• alpha-Glucosidase inhibitors.

  1997cited by this paper
• N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure

  1996cited by this paper
• N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120

  1996cited by this paper
• Total synthesis and chemical design of useful glycosidase inhibitors

  1996cited by this paper
• A New Approach to the Treatment of Nocturnal Hypoglycemia Using Alpha-Glucosidase Inhibition

  1983cited by this paper
• Sucrose malabsorption in man after ingestion of alpha-glucosidehydrolase inhibitor.

  1978cited by this paper
• GLUCAGON IN TREATMENT OF ACUTE PANCREATITIS

  1974cited by this paper

• 4-O-Mono-Fructosyl Phlorizin-Enriched Fraction and Its Interaction with Carbohydrate Digestive Enzymes: In Vitro and In Silico Studies

  2026cites this paper
• Design and Synthesis of Sulfonium and Selenonium Derivatives Bearing 3′,5′-O-Benzylidene Acetal Side Chain Structure as Potent α-Glucosidase Inhibitors

  2025cites this paper
• Broccoli (Brassica oleracea var. italica) leaves exhibit significant antidiabetic potential in alloxan-induced diabetic rats: the putative role of ABC vacuolar transporter for accumulation of Quercetin and Kaempferol

  2024cites this paper
• Artificial intelligence in antidiabetic drug discovery: The advances in QSAR and the prediction of α-glucosidase inhibitors

  2024cites this paper
• Recent Developments in 1,2,3‐Triazole Based α‐Glucosidase Inhibitors: Design Strategies, Structure‐Activity Relationship and Mechanistic Insights

  2024cites this paper
• Antidiabetic Activities and GC-MS Analysis of 4-Methoxychalcone

  2024cites this paper
• Heterocycle-substituted 1,5-benzothiazepines: biological properties and structure–activity relationships

  2024cites this paper
• Synthesis, crystal structure and Hirshfeld surface analysis of 2-({5-[(naphthalen-1-yl)methyl]-4-phenyl-4H-1,2,4-triazol-3-yl}sulfanyl)-1-(4-nitrophenyl)ethanone

  2024cites this paper
• Harnessing Phytochemicals to Regulate Catalytic Residues of Alpha-Amylase and Alpha-Glucosidase in Type 2 Diabetes

  2024influential citation
• Pathogenesis of Alzheimer's Disease and Diversity of 1,2,3-Triazole Scaffold in Drug Development: Design Strategies, Structural Insights, and Therapeutic Potential.

  2023cites this paper
• A Review of the In Vitro Inhibition of α-Amylase and α-Glucosidase by Chalcone Derivatives

  2023cites this paper
• SYNTHESIS, STRUCTURE AND α-GLUCOSIDASE INHIBITOR ACTIVITY EVALUATION OF SOME ACETAMIDE DERIVATIVES STARTING FROM 2-(NAPHTHALEN-1-YL) ACETIC ACID, CONTAINING A 1,2,4-TRIAZOLE

  2023cites this paper
• Design and Synthesis of Sulfonium Derivatives: A Novel Class of α-Glucosidase Inhibitors with Potent In Vivo Antihyperglycemic Activities.

  2023cites this paper
• Copper(II) phthalocyanine as an efficient and versatile catalyst for click reactions at room temperature

  2022cites this paper
• A Fuzzy System Classification Approach for QSAR Modeling of α-Amylase and α-Glucosidase Inhibitors.

  2022cites this paper
• Phytochemical Analysis, α-Glucosidase and Amylase Inhibitory, and Molecular Docking Studies on Persicaria hydropiper L. Leaves Essential Oils

  2022cites this paper
• Synthesis, Conformational Analysis and Evaluation of the 2-aryl-4-(4-bromo-2-hydroxyphenyl)benzo[1,5]thiazepines as Potential α-Glucosidase and/or α-Amylase Inhibitors

  2022cites this paper
• Chalcone derived benzoheterodiazepines for medicinal applications: A Two‐pot and one‐pot synthetic approach

  2021cites this paper
• Water soluble biguanide salts and their 1,3,5-triazine derivatives as inhibitors of acetylcholinesterase and α-glucosidase

  2020cites this paper
• Systematic review on anti-diabetic properties of chalcones.

  2020cites this paper
• Synthesis, inhibition studies against AChE and BChE, drug-like profiling, kinetic analysis and molecular docking studies of N-(4-phenyl-3-aroyl-2(3H)-ylidene) substituted acetamides

  2020cites this paper
• A Multi-layered Variable Selection Strategy for QSAR Modeling of Butyrylcholinesterase Inhibitors.

  2020cites this paper
• Development of diarylpentadienone analogues as alpha-glucosidase inhibitor: Synthesis, in vitro biological and in vivo toxicity evaluations, and molecular docking analysis.

  2020cites this paper
• Biological properties of Cakile maritima Scop. (Brassicaceae) extracts.

  2019cites this paper
• Alpha-glucosidase and amylase inhibitory effects of Eruca vesicaria subsp. longirostris essential oils: synthesis of new 1,2,4-triazole-thiol derivatives and 1,3,4-thiadiazole with potential inhibitory activity

  2019influential citation
• A study towards drug discovery for the management of type 2 diabetes mellitus through inhibition of the carbohydrate-hydrolyzing enzymes α-amylase and α-glucosidase by chalcone derivatives.

  2019cites this paper
• Addition of Olive Leaf Extract (OLE) for Producing Fortified Fresh Pasteurized Milk with an Extended Shelf Life

  2019cites this paper
• Beyond model interpretability using LDA and decision trees for α‐amylase and α‐glucosidase inhibitor classification studies

  2019cites this paper
• A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.

  2018cites this paper
• Molecular Field Topology Analysis (MFTA) in the Design of Neuroprotective Compounds

  2018cites this paper
• Antihyperglycemic Effect of Quercetin in Ovariectomized Rats Treated with Tamoxifen

  2017cites this paper
• Dual Inhibition of AChE and BChE with the C-5 Substituted Derivative of Meldrum’s Acid: Synthesis, Structure Elucidation, and Molecular Docking Studies

  2017cites this paper
• Recent Advances in Synthetic α‐Glucosidase Inhibitors

  2017cites this paper
• The Utilization of the Monte Carlo Technique for Rational Drug Discovery.

  2016cites this paper
• Design, synthesis and biological evaluation of 3'-benzylated analogs of 3'-epi-neoponkoranol as potent α-glucosidase inhibitors.

  2016cites this paper
• 1H and 13C NMR spectral assignments of novel flavonoids bearing benzothiazepine

  2016cites this paper
• Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.

  2015cites this paper
• Computational Modelling of Diverse Chemical, Biochemical and Biomedical Properties

  2015cites this paper